Rationale and strategies for formulation development of oral fixed dose combination drug products
Crossref DOI link: https://doi.org/10.1007/s40005-016-0286-4
Published Online: 2016-11-19
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moon, Cheol
Oh, Euichaul http://orcid.org/0000-0002-8516-245X
License valid from 2016-11-19